|
🐜
|
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
69 auth.
W. Dejnirattisai,
J. Huo,
D. Zhou,
J. Zahradník,
P. Supasa,
Chang Liu,
Helen M. E. Duyvesteyn,
H. Ginn,
A. Mentzer,
A. Tuekprakhon,
Rungtiwa Nutalai,
Beibei Wang,
Aiste Dijokaite,
Suman Khan,
Ori Avinoam,
...
M. Bahar,
D. Skelly,
S. Adele,
Síle A. Johnson,
Thomas G Ritter,
Chris Mason,
C. Dold,
D. Pan,
S. Assadi,
A. Bellass,
Nikki Omo-Dare,
D. Koeckerling,
A. Flaxman,
D. Jenkin,
P. Aley,
M. Voysey,
S. A. Costa Clemens,
F. Naveca,
V. Nascimento,
Fernanda Nascimento,
Cristiano Fernandes da Costa,
P. Resende,
A. Pauvolid-Corrêa,
M. Siqueira,
V. Baillie,
Natali Serafin,
G. Kwatra,
Kelly da Silva,
S. Madhi,
M. Nunes,
Tariq Malik,
P. Openshaw,
J. Baillie,
M. Semple,
A. Townsend,
Kuan-Ying A. Huang,
T. Tan,
M. Carroll,
P. Klenerman,
E. Barnes,
S. Dunachie,
B. Constantinides,
H. Webster,
D. Crook,
A. Pollard,
T. Lambe,
N. Paterson,
Mark A. Williams,
E. Fry,
J. Mongkolsapaya,
Jingshan Ren,
G. Schreiber,
D. Stuart,
G. Screaton
|
9 |
2022 |
9
🐜
|
|
🐜
|
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
69 auth.
W. Dejnirattisai,
J. Huo,
D. Zhou,
J. Zahradník,
P. Supasa,
Chang Liu,
Helen M. E. Duyvesteyn,
H. Ginn,
A. Mentzer,
A. Tuekprakhon,
Rungtiwa Nutalai,
Beibei Wang,
Aiste Dijokaite,
Suman Khan,
Ori Avinoam,
...
M. Bahar,
D. Skelly,
S. Adele,
Síle A. Johnson,
Thomas G Ritter,
Chris Mason,
C. Dold,
D. Pan,
S. Assadi,
A. Bellass,
Nikki Omo-Dare,
D. Koeckerling,
A. Flaxman,
D. Jenkin,
P. Aley,
M. Voysey,
S. A. Costa Clemens,
F. Naveca,
V. Nascimento,
Fernanda Nascimento,
Cristiano Fernandes da Costa,
P. Resende,
A. Pauvolid-Corrêa,
M. Siqueira,
V. Baillie,
Natali Serafin,
Z. Ditse,
Kelly da Silva,
S. Madhi,
M. Nunes,
Tariq Malik,
P. Openshaw,
J. Baillie,
M. Semple,
A. Townsend,
Kuan-Ying A. Huang,
T. Tan,
M. Carroll,
P. Klenerman,
E. Barnes,
S. Dunachie,
B. Constantinides,
H. Webster,
D. Crook,
A. Pollard,
T. Lambe,
N. Paterson,
Mark A. Williams,
E. Fry,
J. Mongkolsapaya,
Jingshan Ren,
G. Schreiber,
David I. Stuart,
G. Screaton
|
6 |
2021 |
6
🐜
|
|
🐜
|
Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19
17 auth.
Caroline M Williams,
D. Pan,
J. Decker,
A. Wiśniewska,
E. Fletcher,
S. Sze,
S. Assadi,
R. Haigh,
M. Abdulwhhab,
P. Bird,
...
C. Holmes,
A. Al-Taie,
B. Saleem,
Jingzhe Pan,
N. Garton,
M. Pareek,
M. Barer
|
5 |
2020 |
5
🐜
|
|
🐜
|
Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission
12 auth.
D. Pan,
Caroline M Williams,
J. Decker,
E. Fletcher,
S. Sze,
S. Assadi,
...
R. Haigh,
B. Saleem,
J. Nazareth,
N. Garton,
M. Pareek,
M. Barer
|
3 |
2022 |
3
🐜
|
|
🦁
|
Could the Use of Antihistamines Have Triggered Reversible Cerebral Vasoconstriction Syndrome? A Case Report
S. Assadi,
L. Rahman,
M. Kong,
S. Asad
|
0 |
2021 |
0
🦁
|
|
🐬
|
La tuberculose aux Comores
P. Feyaerts,
D. Thaoubani,
S. Assadi,
O. Aboubacar,
R. Josse
|
0 |
1995 |
0
🐬
|
|
🐜
|
Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalized patients with acute COVID-19
19 auth.
D. Pan,
J. W. Kim,
J. Nazareth,
S. Assadi,
A. Bellass,
J. Leach,
James G Brosnan,
Adam Ahmed,
Fleur Starcevic,
S. Sze,
...
C. A. Martin,
Caroline M Williams,
M. Barer,
A. Sahota,
P. Patel,
A. Tattersall,
A. Cooper,
M. Pareek,
P. Haldar
|
0 |
2021 |
0
🐜
|
|
🐢
|
Polyneuropathy in patient with human T-cell lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis (HAM-TSP) and HTLV-1 carriers
Zahra Ahmadi,
R. Boostani,
S. Assadi
|
0 |
2016 |
0
🐢
|
|
🦁
|
[Clinical use of intravenous amiodarone for supraventricular arrhythmias].
S. Assadi,
Y. Edoute
|
0 |
1995 |
0
🦁
|
